A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Publication
, Conference
Cohen, AD; Scott, EC; Liedtke, M; Kaufman, JL; Landau, H; Vesole, DH; Gomes, CL; Gasparetto, C; Lentzsch, S; Rosenzweig, M; Sanchorawala, V ...
Published in: BLOOD
December 6, 2014
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 6, 2014
Volume
124
Issue
21
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
56th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Cohen, A. D., Scott, E. C., Liedtke, M., Kaufman, J. L., Landau, H., Vesole, D. H., … Durie, B. G. M. (2014). A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. In BLOOD (Vol. 124). San Francisco, CA: AMER SOC HEMATOLOGY.
Cohen, Adam D., Emma C. Scott, Michaela Liedtke, Jonathan L. Kaufman, Heather Landau, David H. Vesole, Christina L. Gomes, et al. “A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis.” In BLOOD, Vol. 124. AMER SOC HEMATOLOGY, 2014.
Cohen AD, Scott EC, Liedtke M, Kaufman JL, Landau H, Vesole DH, et al. A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. In: BLOOD. AMER SOC HEMATOLOGY; 2014.
Cohen, Adam D., et al. “A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis.” BLOOD, vol. 124, no. 21, AMER SOC HEMATOLOGY, 2014.
Cohen AD, Scott EC, Liedtke M, Kaufman JL, Landau H, Vesole DH, Gomes CL, Gasparetto C, Lentzsch S, Rosenzweig M, Sanchorawala V, Smith DD, Comenzo RL, Durie BGM. A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. BLOOD. AMER SOC HEMATOLOGY; 2014.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 6, 2014
Volume
124
Issue
21
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
56th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology